Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab


  • François Noël Gilly
  • Olivier Glehen
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_852-2



Until the 1980s, “carcinomatosis” was a condition typically characterized by widespread dissemination of malignant metastases throughout the body. It was then used to describe conditions with more limited spread as in “leptomeningeal carcinomatosis,” “lymphangitic carcinomatosis” (which is diffuse malignant infiltration of the lungs with obstruction of the lymphatic channels that occurs most commonly in patients with carcinoma of the breast, lung, stomach, pancreas, prostate, cervix, or thyroid, as well as in patients with metastatic adenocarcinoma from an unknown primary site), and “peritoneal carcinomatosis.” Since 2000, due to the worldwide diffusion of cytoreductive surgery combined with intra-abdominal chemotherapy, “carcinomatosis” is a word now describing tumoral spreading within the peritoneal cavity.

Peritoneum is the mesothelial tissue (serosa) that covers most of the organs in the...


Peritoneal Carcinomatosis Cytoreductive Surgery Intraperitoneal Chemotherapy Peritoneal Cancer Index Pseudomyxoma Peritonei 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Bakrin N et al (2012) Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients. Ann Surg OncolGoogle Scholar
  2. Bakrin N et al (2013) Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients. Eur J Surg OncolGoogle Scholar
  3. Chua TC, et al (2011) Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma. Br J Surg 98(1): 60–64CrossRefPubMedGoogle Scholar
  4. Chua TC et al (2012) Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. J Clin OncolGoogle Scholar
  5. Elias D et al (2010) Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 36(5): 456–462CrossRefPubMedGoogle Scholar
  6. Glehen O, Mohamed F, Gilly FN (2004) Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 5:219–228CrossRefPubMedGoogle Scholar
  7. Glehen O et al (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116(24): 5608–5618CrossRefPubMedGoogle Scholar
  8. Glehen O et al (2014) GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer 14: 183CrossRefPubMedPubMedCentralGoogle Scholar
  9. Sadeghi B, Arvieux C, Glehen O (2000) Peritoneal carcinomatosis from non gynaecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358–363CrossRefPubMedGoogle Scholar
  10. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29–42CrossRefPubMedPubMedCentralGoogle Scholar
  11. Sugarbaker PH, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727–731CrossRefPubMedGoogle Scholar
  12. Verwall VJ, Ruth S, van de Bree E (2003) Randomized trial of cytoréduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery n patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–3743CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of Digestive Oncologic SurgeryHospices Civils de Lyon–Université Lyon 1LyonFrance